Loading chat...
CT HB05714
Bill
Status
1/21/2025
Primary Sponsor
Mark Anderson
Click for details
AI Summary
-
Pharmacists dispensing mifepristone for pregnancy termination would be required to provide written information to patients about the medication's effects
-
Written materials must state that mifepristone's effects may, in some cases, be reversed if the patient decides to continue the pregnancy and seeks reversal treatment in a timely manner
-
Introduced by Rep. Anderson (62nd District) and referred to the Public Health Committee
-
Stated purpose is to protect reproductive rights for women who decide to continue with a pregnancy after initiating medication abortion
Legislative Description
An Act Requiring The Provision Of Written Information By Pharmacists Concerning The Effects Of Mifepristone When Dispensing To A Patient.
Last Action
Referred to Joint Committee on Public Health
1/21/2025